Roche reported a nearly 2% jump in third-quarter sales as the pharmaceutical giant’s cancer drugs continued to power its performance.
from WSJ.com: US Business http://ift.tt/1rwS7fB
via IFTTT
from WSJ.com: US Business http://ift.tt/1rwS7fB
via IFTTT
No comments:
Post a Comment